S93-28324-46921
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 400 / KY
- Registered
- 2021-09-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-18
Registered in v-safe
-
2021-09-18
Dose 1 — Pfizer-BioNTech
- 2021-09-18
-
2021-09-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-09-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-09-21
- 2021-09-22
- 2021-09-24
- 2021-09-25
- 2021-10-02
-
2021-10-20
Dose 2 — Pfizer-BioNTech
- 2021-10-20
-
2021-10-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-22
-
2021-10-23
Survey response — days 1–6 daily, dose 2MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2021-10-24
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-11-05
- 2021-11-26
- 2021-12-01
- 2022-01-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-18 | Pfizer-BioNTech | No |
| 2 | 2021-10-20 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release